{"id":534477,"date":"2021-09-03T21:03:01","date_gmt":"2021-09-04T01:03:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/"},"modified":"2021-09-03T21:03:01","modified_gmt":"2021-09-04T01:03:01","slug":"lost-money-in-sesen-bio-inc-3","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/","title":{"rendered":"Lost Money in Sesen Bio, Inc.?"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }\n.bwuline { text-decoration: underline }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>Lost Money in Sesen Bio, Inc.?<\/b><\/p>\n<p class=\"bwalignc\"><b>Gibbs Law Group Investigates Potential Securities Law Violations<\/b><\/p>\n<p>OAKLAND, Calif.&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nSesen Bio, Inc. investors now have until October 18, 2021, to retain an attorney and seek appointment as lead plaintiff in the <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.classlawgroup.com%2Fsecurities-fraud%2Fsesen-bio-inc-securities-lawsuit%2F&amp;esheet=52486592&amp;newsitemid=20210903005469&amp;lan=en-US&amp;anchor=Sesen+Bio+Securities+Class+Action+Lawsuit&amp;index=1&amp;md5=fd30c8b1704033693ddaf91a5b28a8ff\">Sesen Bio Securities Class Action Lawsuit<\/a>. Gibbs Law Group continues to investigate potential claims against Sesen Bio (NASDAQ: SESN) and offers free consultations to investors. A class action lawsuit has been filed on behalf of investors who purchased Sesen Bio securities between December 21, 2020 and August 17, 2021.\n<\/p>\n<p><b>To speak with an attorney regarding this class action lawsuit investigation, <span class=\"bwuline\"><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.classlawgroup.com%2Fsecurities-fraud%2Fsesen-bio-inc-securities-lawsuit%2F&amp;esheet=52486592&amp;newsitemid=20210903005469&amp;lan=en-US&amp;anchor=click+here&amp;index=2&amp;md5=31161ef36f1f6e14a34f281dc0ac3f81\">click here<\/a><\/span> or <\/b><b>call<\/b><b>(888) 410-2925.<\/b><\/p>\n<p>\nOn August 13, 2021, Sesen Bio reported its bladder cancer drug Vicineum failed to receive approval from the FDA. The company had received a complete response letter (CRL) that included recommendations addressing \u201cadditional clinical\/statistical data and analyses\u201d as well as \u201cChemistry, Manufacturing and Controls (CMC) issues.\u201d Sesen Bio\u2019s CEO claimed the result was \u201cunexpected.\u201d\n<\/p>\n<p>\nThen on August 18, 2021, STAT News said it received internal documents allegedly revealing that the drug Vicineum had caused a patient death, and Sesen Bio had concealed the death in its reports on the drug. STAT further alleged that multiple doctors acting as investigators in the study had been found to be engaging in unethical behavior, including \u201cback-dating data\u201d and worse, \u201c[placing] subjects at risk of harm.\u201d\n<\/p>\n<p>\nThe patient death in Sesen Bio\u2019s study allegedly occurred in 2016 and was \u201cdrug-related,\u201d but STAT claims Sesen Bio failed to mention this death in subsequent reports, including a presentation at a major urology conference in 2018. Further, STAT reported in 2017 and 2018, an outside firm hired by Sesen Bio found three doctors in the Vicineum study were engaging in \u201cserious noncompliance\u201d that \u201cplaced subjects at risk of harm.\u201d Another doctor in the study allegedly had his clinic closed in 2017 by his hospital\u2019s disciplinary committee, and a separate doctor was found to be \u201cback-dating data.\u201d STAT further alleges Sesen Bio used data from these doctors in its application for FDA approval of Vicineum, despite being advised by an outside investigator that their data \u201ccannot be used in any data analysis.\u201d\n<\/p>\n<p>\nFollowing STAT\u2019s report, Sesen Bio\u2019s stock price dropped 13% on August 18, 2021, causing significant harm to investors.\n<\/p>\n<p><b>What Should Sesen Bio Investors Do?<\/b><\/p>\n<p>\nIf you invested in Sesen Bio, visit our <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.classlawgroup.com%2Fsecurities-fraud%2Fsesen-bio-inc-securities-lawsuit%2F&amp;esheet=52486592&amp;newsitemid=20210903005469&amp;lan=en-US&amp;anchor=website&amp;index=3&amp;md5=2808176c05014337532dc2929bc8b105\">website<\/a> or contact our securities team directly at <b>(888) 410-2925 <\/b>to discuss how you may be able to recover your losses. Our investigation concerns whether Sesen Bio has violated federal securities laws by providing false or misleading statements to investors.\n<\/p>\n<p><b>About Gibbs Law Group<\/b><\/p>\n<p>\nGibbs Law Group represents investors throughout the country in <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.classlawgroup.com%2Fsecurities-fraud%2Finvestment%2F&amp;esheet=52486592&amp;newsitemid=20210903005469&amp;lan=en-US&amp;anchor=securities+litigation&amp;index=4&amp;md5=9d51b39e7d66ccacb19b9bd1c7b294cc\">securities litigation<\/a> to correct abusive corporate governance practices, breaches of fiduciary duty, and proxy violations. The firm has recovered over a billion dollars for its clients against some of the world\u2019s largest corporations, and our attorneys have received numerous honors for their work, including \u201cBest Lawyers in America,\u201d \u201cTop Plaintiff Lawyers in California,\u201d \u201cCalifornia Lawyer Attorney of the Year,\u201d \u201cClass Action Practice Group of the Year,\u201d \u201cConsumer Protection MVP,\u201d and \u201cTop Women Lawyers in California.\u201d\n<\/p>\n<p><i>This press release may constitute Attorney Advertising in some jurisdictions under the applicable law and ethical rules. <\/i><\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210903005469r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20210903005469\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20210903005469\/en\/<\/a><\/span><\/p>\n<p>\nEILEEN EPSTEIN<br \/>\n<br \/>PHONE: 510.350.9728<br \/>\n<br \/>EMAIL: <a rel=\"nofollow\" href=\"mailto:EJE@CLASSLAWGROUP.COM\">EJE@CLASSLAWGROUP.COM<\/a><\/p>\n<p><b>KEYWORDS:<\/b> United States North America California<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Legal Professional Services<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\">\n<tr>\n<td><font face=\"Arial\" size=\"2\"><b>Logo<\/b><\/font><\/td>\n<\/tr>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20210903005469\/en\/903211\/3\/GLG_securities_press_release_logo_v2.jpg\" alt=\"Logo\" \/><\/td>\n<\/tr>\n<tr>\n<td><font face=\"Arial\" size=\"2\"><\/font><\/td>\n<\/tr>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Lost Money in Sesen Bio, Inc.? Gibbs Law Group Investigates Potential Securities Law Violations OAKLAND, Calif.&#8211;(BUSINESS WIRE)&#8211; Sesen Bio, Inc. investors now have until October 18, 2021, to retain an attorney and seek appointment as lead plaintiff in the Sesen Bio Securities Class Action Lawsuit. Gibbs Law Group continues to investigate potential claims against Sesen Bio (NASDAQ: SESN) and offers free consultations to investors. A class action lawsuit has been filed on behalf of investors who purchased Sesen Bio securities between December 21, 2020 and August 17, 2021. To speak with an attorney regarding this class action lawsuit investigation, click here or call(888) 410-2925. On August 13, 2021, Sesen Bio reported its bladder cancer drug Vicineum failed to receive approval &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Lost Money in Sesen Bio, Inc.?&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-534477","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lost Money in Sesen Bio, Inc.? - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Lost Money in Sesen Bio, Inc.? - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Lost Money in Sesen Bio, Inc.? Gibbs Law Group Investigates Potential Securities Law Violations OAKLAND, Calif.&#8211;(BUSINESS WIRE)&#8211; Sesen Bio, Inc. investors now have until October 18, 2021, to retain an attorney and seek appointment as lead plaintiff in the Sesen Bio Securities Class Action Lawsuit. Gibbs Law Group continues to investigate potential claims against Sesen Bio (NASDAQ: SESN) and offers free consultations to investors. A class action lawsuit has been filed on behalf of investors who purchased Sesen Bio securities between December 21, 2020 and August 17, 2021. To speak with an attorney regarding this class action lawsuit investigation, click here or call(888) 410-2925. On August 13, 2021, Sesen Bio reported its bladder cancer drug Vicineum failed to receive approval &hellip; Continue reading &quot;Lost Money in Sesen Bio, Inc.?&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-04T01:03:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210903005469r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-in-sesen-bio-inc-3\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-in-sesen-bio-inc-3\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Lost Money in Sesen Bio, Inc.?\",\"datePublished\":\"2021-09-04T01:03:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-in-sesen-bio-inc-3\\\/\"},\"wordCount\":565,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-in-sesen-bio-inc-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210903005469r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-in-sesen-bio-inc-3\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-in-sesen-bio-inc-3\\\/\",\"name\":\"Lost Money in Sesen Bio, Inc.? - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-in-sesen-bio-inc-3\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-in-sesen-bio-inc-3\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210903005469r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2021-09-04T01:03:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-in-sesen-bio-inc-3\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-in-sesen-bio-inc-3\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-in-sesen-bio-inc-3\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210903005469r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20210903005469r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/lost-money-in-sesen-bio-inc-3\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lost Money in Sesen Bio, Inc.?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lost Money in Sesen Bio, Inc.? - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/","og_locale":"en_US","og_type":"article","og_title":"Lost Money in Sesen Bio, Inc.? - Market Newsdesk","og_description":"Lost Money in Sesen Bio, Inc.? Gibbs Law Group Investigates Potential Securities Law Violations OAKLAND, Calif.&#8211;(BUSINESS WIRE)&#8211; Sesen Bio, Inc. investors now have until October 18, 2021, to retain an attorney and seek appointment as lead plaintiff in the Sesen Bio Securities Class Action Lawsuit. Gibbs Law Group continues to investigate potential claims against Sesen Bio (NASDAQ: SESN) and offers free consultations to investors. A class action lawsuit has been filed on behalf of investors who purchased Sesen Bio securities between December 21, 2020 and August 17, 2021. To speak with an attorney regarding this class action lawsuit investigation, click here or call(888) 410-2925. On August 13, 2021, Sesen Bio reported its bladder cancer drug Vicineum failed to receive approval &hellip; Continue reading \"Lost Money in Sesen Bio, Inc.?\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/","og_site_name":"Market Newsdesk","article_published_time":"2021-09-04T01:03:01+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210903005469r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Lost Money in Sesen Bio, Inc.?","datePublished":"2021-09-04T01:03:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/"},"wordCount":565,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210903005469r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/","name":"Lost Money in Sesen Bio, Inc.? - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210903005469r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2021-09-04T01:03:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210903005469r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20210903005469r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/lost-money-in-sesen-bio-inc-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Lost Money in Sesen Bio, Inc.?"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=534477"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/534477\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=534477"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=534477"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=534477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}